tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMRN Stock Latest News

Positive Outlook on BioMarin Pharmaceutical: Strong Financials and Promising Pipeline Drive Buy Rating
RatingsPositive Outlook on BioMarin Pharmaceutical: Strong Financials and Promising Pipeline Drive Buy Rating
3d ago
BMRN
BioMarin’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
BioMarin’s Earnings Call: Growth Amid Challenges
3d ago
BMRN
BioMarin price target raised to $114 from $113 at UBS
PremiumThe Fly
BioMarin price target raised to $114 from $113 at UBS
4d ago
BMRN
3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts
4d ago
BMRN
MSTR
BioMarin Pharmaceutical: Strong Financial Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
BioMarin Pharmaceutical: Strong Financial Performance and Promising Pipeline Justify Buy Rating
4d ago
BMRN
BioMarin Pharmaceutical: Strong Financial Performance and Promising Future Drive Buy Rating
PremiumRatingsBioMarin Pharmaceutical: Strong Financial Performance and Promising Future Drive Buy Rating
4d ago
BMRN
BioMarin Pharmaceutical Inc. Reports Strong Q2 2025 Results
Premium
Company Announcements
BioMarin Pharmaceutical Inc. Reports Strong Q2 2025 Results
4d ago
BMRN
Positive Outlook for BioMarin Pharmaceutical Driven by Strong Financial Performance and Growth Opportunities
Premium
Ratings
Positive Outlook for BioMarin Pharmaceutical Driven by Strong Financial Performance and Growth Opportunities
5d ago
BMRN
BioMarin Pharmaceutical: Strong Q2 Performance and Promising Future Drive Buy Rating
PremiumRatings
BioMarin Pharmaceutical: Strong Q2 Performance and Promising Future Drive Buy Rating
5d ago
BMRN
Closing Bell Movers: Palantir hits record highs on beat and raise
PremiumThe Fly
Closing Bell Movers: Palantir hits record highs on beat and raise
5d ago
AL
KD
BioMarin reports Q2 adjusted EPS $1.44, consensus $1.01
PremiumThe Fly
BioMarin reports Q2 adjusted EPS $1.44, consensus $1.01
5d ago
BMRN
BioMarin raises FY25 adjusted EPS view to $4.40-$4.55 from $4.20-$4.40
PremiumThe Fly
BioMarin raises FY25 adjusted EPS view to $4.40-$4.55 from $4.20-$4.40
5d ago
BMRN
BMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsBMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
BMRN
BioMarin Expands Board with New Director Appointment
Premium
Company Announcements
BioMarin Expands Board with New Director Appointment
8d ago
8K
BMRN
PTC Therapeutics price target raised to $46 from $42 at Barclays
Premium
The Fly
PTC Therapeutics price target raised to $46 from $42 at Barclays
11d ago
BMRN
PTCT
BioMarin’s BMN 349: A Promising Step in Genetic Lung Condition Treatment
PremiumCompany Announcements
BioMarin’s BMN 349: A Promising Step in Genetic Lung Condition Treatment
16d ago
BMRN
3 “Strong Buy” Value Stocks to Buy Now, 7/23/2025, According to Analysts 
PremiumMarket News
3 “Strong Buy” Value Stocks to Buy Now, 7/23/2025, According to Analysts 
17d ago
T
ALV
BioMarin Pharmaceutical’s Strategic Growth and Market Position Enhancement: A Buy Rating with a $105 Price Target
PremiumRatings
BioMarin Pharmaceutical’s Strategic Growth and Market Position Enhancement: A Buy Rating with a $105 Price Target
17d ago
BMRN
BioMarin price target lowered to $96 from $97 at Morgan Stanley
PremiumThe Fly
BioMarin price target lowered to $96 from $97 at Morgan Stanley
18d ago
BMRN
BioMarin Pharmaceutical: Undervalued Stock with Promising Growth Catalysts and Positive Outlook
PremiumRatingsBioMarin Pharmaceutical: Undervalued Stock with Promising Growth Catalysts and Positive Outlook
18d ago
BMRN
BioMarin’s BMN 349 Study: A Potential Game-Changer in Genetic Disorder Treatment
Premium
Company Announcements
BioMarin’s BMN 349 Study: A Potential Game-Changer in Genetic Disorder Treatment
23d ago
BMRN
BioMarin price target raised to $113 from $108 at JPMorgan
Premium
The Fly
BioMarin price target raised to $113 from $108 at JPMorgan
26d ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >